Checkpoint Capital L.P.
- SEC CIK
- 0001977548
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 8
- −6 vs. Q1 2025
- Portfolio value
- $214.6M
- +$32.3M (+17.7%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 149,977 | $82.7M | 38.5% | +34,977+30.4% | Added | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 1,060,000 | $67.0M | 31.2% | +152,760+16.8% | Added | History |
| CORTCorcept Therapeutics Inc | COM | 343,917 | $25.2M | 11.8% | +338,917+6,778.3% | Added | History |
| IRONDisc Medicine, Inc. | COM | 265,000 | $14.0M | 6.5% | +21,689+8.9% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 280,000 | $10.3M | 4.8% | −112,011−28.6% | Reduced | History |
| SEPNSepterna, Inc. | COM | 586,473 | $6.20M | 2.9% | −238,405−28.9% | Reduced | History |
| KYMRKymera Therapeutics, Inc. | COM | 106,991 | $4.67M | 2.2% | −29,614−21.7% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 81,311 | $4.49M | 2.1% | −93,873−53.6% | Reduced | History |
Sold out since Q1 2025 (6)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| SLNOSoleno Therapeutics Inc | COM | 172,902 | $12.4M | 6.8% | History |
| STOKStoke Therapeutics, Inc. | COM | 730,717 | $4.86M | 2.7% | History |
| TCRXTScan Therapeutics, Inc. | COM | 2,017,650 | $2.78M | 1.5% | History |
| CDTXCidara Therapeutics, Inc. | COM NEW | 104,380 | $2.25M | 1.2% | History |
| IMCRImmunocore Holdings plc | ADS | 9,011 | $267.4K | 0.1% | History |
| RAPTRAPT Therapeutics, Inc. | COM | 109,830 | $134.0K | 0.1% | History |